In this interview, we sit down with Eeva Broberg, ECDC Principal Expert on respiratory viruses, who tells us why respiratory syncytial virus (RSV) is an often overlooked disease which represents a considerable risk to certain groups every winter.
Eeva also talks about the impact on healthcare, and whether current treatments like monoclonal antibodies and the introduction of vaccines in Europe are a game changer.
Podden och tillhörande omslagsbild på den här sidan tillhör
European Centre for Disease Prevention and Control. Innehållet i podden är skapat av European Centre for Disease Prevention and Control och inte av,
eller tillsammans med, Poddtoppen.
